Neurokinin A is an endogenous tachykinin agonist with preference for the NK-2R
CAT No: 10-101-295
CAS No:86933-74-6
Synonyms/Alias:NEUROKININ A;86933-74-6;Neurokinin alpha;Substance K;Neuromedin L;Neurokinin A (alligator);Porcine neurokinin A;Neurokinin A (Python molurus);Neurokinin alpha (porcine);Neurokinin A (pig spinal cord);Neuromedin L (pig spinal cord);Neurokinin A (swine spinal cord);Neurokinin alpha (pig spinal cord);94168F9W1D;CHEMBL217406;Neurokinin A trifluoroacetate salt;DTXSID701027125;Kassinin, 1-de-L-aspartic acid-2-de-L-valine-3-L-histidine-5-L-threonine-7-L-serine-;His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2;L-Methioninamide, L-histidyl-L-lysyl-L-threonyl-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl-;(5S,8S,14S,17S,20S,23S)-23-((2S,3R)-2-((S)-6-amino-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)hexanamido)-3-hydroxybutanamido)-17-benzyl-5-carbamoyl-20-(hydroxymethyl)-8-isobutyl-14-isopropyl-7,10,13,16,19,22-hexaoxo-2-thia-6,9,12,15,18,21-hexaazapentacosan-25-oic acid;L-HISTIDYL-L-LYSYL-L-THREONYL-L-.ALPHA.-ASPARTYL-L-SERYL-L-PHENYLALANYL-L-VALYLGLYCYL-L-LEUCYL-L-METHIONINAMIDE;L-METHIONINAMIDE, L-HISTIDYL-L-LYSYL-L-THREONYL-L-.ALPHA.-ASPARTYL-L-SERYL-L-PHENYLALANYL-L-VALYLGLYCYL-L-LEUCYL-;NKA;[125I]-neurokinin A;GTPL2089;GTPL3795;UNII-94168F9W1D;[125I]-NKA;DTXCID501511356;[125I]NKA (human, mouse, rat);BDBM50001447;-Neurokinin;Neuromedin L;Substance K;AKOS024456420;AKOS040763868;DA-76125;FN109083;TS-10268;G12445;His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH(2);His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2(NeurokininA);H-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2; H-HKTDSFVGLM-NH2;(3S)-3-[(2S,3R)-2-[(2S)-6-AMINO-2-[(2S)-2-AMINO-3-(1H-IMIDAZOL-4-YL)PROPANAMIDO]HEXANAMIDO]-3-HYDROXYBUTANAMIDO]-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-1-CARBAMOYL-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}METHYL)CARBAMOYL]-2-METHYLPROPYL]CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}PROPANOIC ACID;L-HISTIDYL-L-LYSYL-L-THREONYL-L-ALPHA-ASPARTYL-L-SERYL-L-PHENYLALANYL-L-VALYLGLYCYL-L-LEUCYL-L-METHIONINAMIDE;
Chemical Name:(3S)-3-[[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.